☆ 4.7 Article

Description of Symptoms Caused by the Infection of the SARS-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme: First Case Report From Santiago of Chile

FRONTIERS IN PUBLIC HEALTH (2022)

Related references

Note: Only part of the references are listed.

Article Virology

Analysis by real-time PCR of five transport and conservation mediums of nasopharyngeal swab samples to COVID-19 diagnosis in Santiago of Chile

Carlos Barrera-Avalos et al.

Summary: This study compared the performance of different viral transport media in COVID-19 diagnosis in Santiago, Chile, finding DNA/RNA Shield (TM) to be more effective. PBS medium may compromise sample diagnosis, while NAT, Ezmedlab, VTM-N, and DNA/RNA Shield (TM) media show acceptable RT-qPCR parameters.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Infectious Diseases

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2

Katherine Laiton-Donato et al.

Summary: The emergence of the B.1.621 lineage, considered a variant of interest (VOI), with substitutions affecting the Spike protein, has the potential to impact the epidemiology of the virus. In cities near theoretical herd immunity, this lineage has rapidly increased in frequency, indicating a possible epidemiologic impact. Further studies are needed to assess the biological and epidemiologic roles of the substitutions found in the B.1.621 lineage.

INFECTION GENETICS AND EVOLUTION (2021)

Add to Collection

Letter Medicine, General & Internal

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum

Keiya Uriu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers

Francesca Rovida et al.

Summary: A study of healthcare workers vaccinated with BNT162b2 vaccine showed an 83% protection rate against SARS-CoV-2 infection in the overall population and 93% in previously infected individuals. Evidence of virus transmission was low, with breakthrough infections mostly asymptomatic or mild, supporting the real-world effectiveness of the vaccine.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Medicine, General & Internal

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Ezgi Hacisuleyman et al.

Summary: Despite evidence of vaccine efficacy, two fully vaccinated individuals developed mild symptoms of Covid-19 and were infected with variants of SARS-CoV-2. Sequencing of the virus isolates revealed novel mutations, highlighting the potential risk of illness post-vaccination and subsequent infection with variant virus. Efforts to prevent, diagnose, and characterize variants in vaccinated individuals are crucial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in Sao Paulo, Brazil

Karoline Rodrigues Campos et al.

Summary: COVID-19 vaccination began in Sao Paulo, Brazil in January 2021, targeting healthcare workers and the elderly first. Studies have shown efficacy of the vaccines in preventing severe cases and deaths. Data from the Instituto Adolfo Lutz in Sao Paulo revealed that most severe cases were among CoronaVac vaccinated individuals with the gamma variant.

REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2021)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants Comment

Muge Cevik et al.

Summary: As the SARS-CoV-2 pandemic progresses, new variants are emerging, with some highly transmissible variants like Delta raising concerns about vaccine effectiveness. Understanding the immunological correlates of protection and how laboratory findings relate to clinical effectiveness is crucial for shaping future vaccination strategies.

CELL (2021)

Add to Collection

Letter Virology

A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine

Serena Messali et al.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Alejandro Jara et al.

Summary: A study in Chile involving 10.2 million participants assessed the effectiveness of an inactivated SARS-CoV-2 vaccine developed in China. Fully immunized individuals had vaccine effectiveness of 65.9% for preventing Covid-19 and 87.5% for preventing hospitalization, 90.3% for preventing ICU admission, and 86.3% for preventing death.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach

Oguzhan Alagoz et al.

Summary: The control of SARS-CoV-2 spread relies not only on the effectiveness and coverage of vaccines, but also on concurrent adherence to nonpharmaceutical interventions, such as wearing masks and maintaining social distancing.

PLOS ONE (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study

Otavio Ranzani et al.

Summary: The study evaluates the effectiveness of the CoronaVac vaccine in the elderly population aged >= 70 years in Sao Paulo state, Brazil during widespread circulation of the gamma variant. The vaccine was found to significantly reduce the risk of symptomatic covid-19, hospital admissions, and deaths after completion of the two-dose regimen, but the effectiveness decreases with age among the elderly population.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Health Care Sciences & Services

Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study

Matt D. T. Hitchings et al.

Summary: The study found that CoronaVac vaccine was effective in reducing symptomatic SARS-CoV-2 infection among healthcare workers in Manaus, especially during the Gamma variant epidemic, but the effectiveness of the two-dose schedule was low.

LANCET REGIONAL HEALTH-AMERICAS (2021)

Add to Collection

Article Health Care Sciences & Services

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel

Gili Regev-Yochay et al.

Summary: The study found that the BNT162b2 vaccine is moderately to highly effective in reducing infectivity by preventing infection and reducing viral shedding.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Review Mycology

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature

Deepak Garg et al.

Summary: The study discussed a case of probable pulmonary mucormycosis in a COVID-19 patient, highlighting the severity of the disease and the importance of aggressive management for better outcomes. A systematic review revealed that diabetes mellitus was the most common risk factor, and the concurrent use of glucocorticoids may also increase the risk of mucormycosis.

MYCOPATHOLOGIA (2021)

Add to Collection

Article Health Care Sciences & Services

Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province

Jitian Li et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2020)

Add to Collection

Article Virology

Efficient SARS-CoV-2 detection in unextracted oro-nasopharyngeal specimens by rRT-PCR with the Seegene Allplex™ 2019-nCoV assay

Wesley Freppel et al.

VIROLOGY JOURNAL (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology

Alexander Kamyshnyi et al.

INTERNATIONAL JOURNAL OF HYPERTENSION (2020)

Add to Collection

Review Immunology

Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity

Soo-Jin Oh et al.

IMMUNE NETWORK (2019)

Add to Collection

© Peeref 2019-2024. All rights reserved.